Issue 7 of SF Pulse is out now!
The issue highlights the following:
- Inadequate Legal Frameworks: On the Center for Innovation and Intellectual Property Rights blog, Komal & Aarish Alam argue that India’s legal and regulatory systems are not well-suited to address the proliferation of substandard medicines.
- An Urgent Call: At the Financial Express, Johns Hopkins Senior Associate Indu Bushan argues despite these challenges, greater focus is needed in India.
- One Thing Leads to Another: A new study published in BMJ Global Health is the first of its kind to demonstrate a positive association between the prevalence of substandard and falsified antibiotics and antimicrobial resistance.
- Chemical Detective: Bioengineer takes a closer look at a new scientific method, jointly developed by researchers at the University of Copenhagen and Stanford University, to counteract pharmaceutical crime. The method, which analyzes the stable isotopic fingerprints of medicines, acts as a “chemical detective” to distinguish between legitimate and illicit drugs that look identical.
- Improving RSA’s Response: In an op-ed for Mail & Guardian, pharmacology student Fenste Maseko argues that advancing efforts to combat SFs in South Africa necessitates a more aggressive approach by stakeholders.
- Hard Truths: Writing for the Premium Times, Eliangiringa Kaale lays bare the many challenges African leaders face in curbing use of substandard and falsified medicines.
- Package Check: UPU recounts the success of a four-day, multi-stakeholder initiative last year called Operation Star, centered around thwarting the distribution of unsafe medicines via postal networks.
Read the full issue here: https://bit.ly/4nwhiD2
